FTXH holdings — First Trust Nasdaq Pharmaceuticals ETF
First Trust Nasdaq Pharmaceuticals ETF (FTXH) held 51 positions with net assets of $36.2M as of June 30, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 53.1% of the fund, led by LLY, ABBV, MRK.
FTXH top holdings
- LLY ELI LILLY & COMPANY — 7.77% ($2.82M)
- ABBV ABBVIE INC — 7.39% ($2.68M)
- MRK MERCK & COMPANY INC — 7.07% ($2.56M)
- JNJ JOHNSON & JOHNSON — 6.96% ($2.52M)
- BMY BRISTOL-MYERS SQUIBB COMPANY — 6.29% ($2.28M)
- BIIB BIOGEN INC — 3.84% ($1.39M)
- VTRS VIATRIS INC — 3.62% ($1.31M)
- CAH CARDINAL HEALTH INC — 3.53% ($1.28M)
- VRTX VERTEX PHARMACEUTICALS INC — 3.41% ($1.23M)
- AMGN AMGEN INC — 3.18% ($1.15M)
- PFE PFIZER INC — 2.97% ($1.08M)
- GILD GILEAD SCIENCES INC — 2.89% ($1.05M)
- UTHR UNITED THERAPEUTICS CORP — 2.72% ($987K)
- REGN REGENERON PHARMACEUTICALS INC — 2.72% ($985K)
- JAZZ JAZZ PHARMACEUTICALS PLC — 2.49% ($901K)
- INCY INCYTE CORP — 2.39% ($867K)
- ILMN ILLUMINA INC — 1.98% ($719K)
- ZTS ZOETIS INC — 1.87% ($677K)
- EXEL EXELIXIS INC — 1.72% ($625K)
- CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC — 1.49% ($539K)
- MEDP MEDPACE HOLDINGS INC — 1.41% ($512K)
- PTCT PTC THERAPEUTICS INC — 1.37% ($497K)
- NBIX NEUROCRINE BIOSCIENCES INC — 1.37% ($495K)
- ALKS ALKERMES PLC — 1.35% ($491K)
- HALO HALOZYME THERAPEUTICS INC — 1.21% ($438K)
What are FTXH's top 10 holdings?
LLY (7.8%), ABBV (7.4%), MRK (7.1%), JNJ (7.0%), BMY (6.3%), BIIB (3.8%), VTRS (3.6%), CAH (3.5%), VRTX (3.4%), AMGN (3.2%).
How many stocks are in FTXH?
First Trust Nasdaq Pharmaceuticals ETF reported 51 holdings as of June 30, 2026.